Financial statements Niroprim
Balance sheet of Niroprim
Company age:
Age:
23 y. 6 m. 20 d.
Share capital:
Share capital:
50 000 PLN
Balance sheet data of NIROPRIM
|
Year
|
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
|---|---|---|---|---|---|---|
| Total assets | 1 094 269,33 | 1 112 516,06 | 1 169 923,34 | 1 202 339,23 | 1 210 986,13 | 1 539 061,51 |
| A. Fixed assets | 626 031,79 | 633 653,65 | 613 687,20 | 611 036,37 | 564 095,82 | 532 668,07 |
| B. Current assets | 468 237,54 | 478 862,41 | 556 236,14 | 591 302,86 | 646 890,31 | 1 006 393,44 |
| C. Share capital contributions (basic funds) | 0,00 | 0,00 | 0,00 | - | - | - |
| D. Own shares (stocks) | 0,00 | 0,00 | 0,00 | - | - | - |
| Total liabilities | 1 094 269,33 | 1 112 516,06 | 1 169 923,34 | 1 202 339,23 | 1 210 986,13 | 1 539 061,51 |
| A. Equity | 741 854,53 | 750 525,33 | 794 240,09 | 857 377,68 | 898 611,19 | 992 417,40 |
| B. Liabilities and provisions for liabilities | 352 414,80 | 361 990,73 | 375 683,25 | 344 961,55 | 312 374,94 | 546 644,11 |
| I. Long-term liabilities | 8 160,00 | 8 160,00 | 0,00 | - | - | - |
| II. Short-term liabilities | 226 451,32 | 236 027,25 | 269 921,41 | 251 241,35 | 230 696,38 | 477 006,93 |
Financial data is automatically retrieved from the EKRS webpage of the Ministry of Justice.
- Fixed Assets - Assets held for a longer period, typically longer than a year, such as real estate or machinery.
- Current Assets - Assets intended to be used or sold within a year, such as inventory, receivables, and cash.
- Equity - The net value of a company's assets, representing the difference between its assets and liabilities.
- Long-Term Liabilities - Financial obligations to be repaid over a period longer than a year, such as loans or bonds.
- Short-Term Liabilities - Financial obligations to be repaid within a year, such as payables to suppliers or short-term loans.
- Reserve Capital - A portion of equity set aside for specific purposes, such as covering losses or business development.